Cargando…
Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide. Specifically, typical late-onset AD is a sporadic form with a complex etiology that affects over 90% of patients. The current gold standard for AD diagnosis is based on the determination of amyloid status by analyzing...
Autores principales: | Casas-Fernández, Esther, Peña-Bautista, Carmen, Baquero, Miguel, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881089/ https://www.ncbi.nlm.nih.gov/pubmed/34727857 http://dx.doi.org/10.2174/1570159X19666211102150955 |
Ejemplares similares
-
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
por: Mayo, Sonia, et al.
Publicado: (2021) -
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022) -
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)